Moreover, it has been demonstrated that TNFR2 agonists expand Tregs (40, 44), which have been proposed to play a beneficial role in AD by promoting a type 1 interferon–dependent protective activation profile in microglia (45). The gene discussed is TNFRSF1B; the disease is Alzheimer disease.